Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R, Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, Bedford P, Lang J, Quentin-Millet MJ, Monath TP.

Hum Vaccin. 2006 Mar-Apr;2(2):60-7. Epub 2006 Mar 15.

PMID:
17012873
2.

Recombination and flavivirus vaccines: a commentary.

Monath TP, Kanesa-Thasan N, Guirakhoo F, Pugachev K, Almond J, Lang J, Quentin-Millet MJ, Barrett AD, Brinton MA, Cetron MS, Barwick RS, Chambers TJ, Halstead SB, Roehrig JT, Kinney RM, Rico-Hesse R, Strauss JH.

Vaccine. 2005 Apr 27;23(23):2956-8. No abstract available.

PMID:
15811640
3.

Role of transferrin receptor from a Neisseria meningitidis tbpB isotype II strain in human transferrin binding and virulence.

Renauld-Mongénie G, Poncet D, Mignon M, Fraysse S, Chabanel C, Danve B, Krell T, Quentin-Millet MJ.

Infect Immun. 2004 Jun;72(6):3461-70.

4.

Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis.

Hot D, Antoine R, Renauld-Mongénie G, Caro V, Hennuy B, Levillain E, Huot L, Wittmann G, Poncet D, Jacob-Dubuisson F, Guyard C, Rimlinger F, Aujame L, Godfroid E, Guiso N, Quentin-Millet MJ, Lemoine Y, Locht C.

Mol Genet Genomics. 2003 Jul;269(4):475-86. Epub 2003 May 24.

PMID:
12768411
5.

Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR.

Rokbi B, Seguin D, Guy B, Mazarin V, Vidor E, Mion F, Cadoz M, Quentin-Millet MJ.

Infect Immun. 2001 Aug;69(8):4759-66.

8.

Both the full-length and the N-terminal domain of the meningococcal transferrin-binding protein B discriminate between human iron-loaded and apo-transferrin.

Renauld-Mongénie G, Latour M, Poncet D, Naville S, Quentin-Millet MJ.

FEMS Microbiol Lett. 1998 Dec 1;169(1):171-7.

9.

Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B.

Renauld-Mongénie G, Poncet D, von Olleschik-Elbheim L, Cournez T, Mignon M, Schmidt MA, Quentin-Millet MJ.

J Bacteriol. 1997 Oct;179(20):6400-7.

10.
12.

Molecular characterization of hybrid Tbp2 proteins from Neisseria meningitidis.

Legrain M, Findeli A, Villeval D, Quentin-Millet MJ, Jacobs E.

Mol Microbiol. 1996 Jan;19(1):159-69.

PMID:
8821945
13.

Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes.

Rokbi B, Maitre-Wilmotte G, Mazarin V, Fourrichon L, Lissolo L, Quentin-Millet MJ.

FEMS Microbiol Lett. 1995 Oct 15;132(3):277-83.

PMID:
7590185
14.

Diversity of the transferrin-binding protein Tbp2 of Neisseria meningitidis.

Mazarin V, Rokbi B, Quentin-Millet MJ.

Gene. 1995 May 26;158(1):145-6.

PMID:
7789801
15.

Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.

Lissolo L, Maitre-Wilmotte G, Dumas P, Mignon M, Danve B, Quentin-Millet MJ.

Infect Immun. 1995 Mar;63(3):884-90.

16.

Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals.

Danve B, Lissolo L, Mignon M, Dumas P, Colombani S, Schryvers AB, Quentin-Millet MJ.

Vaccine. 1993 Sep;11(12):1214-20.

PMID:
8256502
17.

Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2.

Legrain M, Mazarin V, Irwin SW, Bouchon B, Quentin-Millet MJ, Jacobs E, Schryvers AB.

Gene. 1993 Aug 16;130(1):73-80.

PMID:
8344530
18.

Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features.

Rokbi B, Mazarin V, Maitre-Wilmotte G, Quentin-Millet MJ.

FEMS Microbiol Lett. 1993 Jun 1;110(1):51-7.

PMID:
8319895
19.

Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.

Khelef N, Danve B, Quentin-Millet MJ, Guiso N.

Infect Immun. 1993 Feb;61(2):486-90.

20.

Acellular pertussis vaccines: evaluation of reversion in a nude mouse model.

Quentin-Millet MJ, Arminjon F, Danve B, Cadoz M, Armand J.

J Biol Stand. 1988 Apr;16(2):99-108.

PMID:
3259580

Supplemental Content

Loading ...
Support Center